Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Female hair loss is influenced by genetics and hormones, often starting in middle age or after hormonal changes.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Women with PCOS often have more hair growth, skin darkening, and acne, which are linked to hormonal and metabolic issues.

The main cause of hirsutism in Algerian women is polycystic ovary syndrome, and those affected should be checked for related hormonal issues.

Goat hair follicles have insulin-like growth factor-I receptors that might affect hair growth, but no melatonin receptors were found.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Acne and hair loss are not good indicators of hormone imbalance in PCOS, but excessive body hair is.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

PCOS often causes skin issues like excess hair, acne, hair thinning, and dark patches due to hormone imbalances and insulin resistance.

NAG-1 may help prevent some metabolic issues related to PCOS.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Women with PCOS have significant metabolic issues like insulin resistance after eating a high-fat meal.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Women with PCOS have higher levels of certain hormones compared to healthy women, and these levels vary with BMI, age, and treatment type.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Early menarche may indicate higher risk of severe hirsutism in PCOS patients.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Higher 3α,5α-THP levels in the brain may reduce depression in pregnant rats.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Higher prolactin levels in women may be linked to pilonidal sinus disease.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.